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abstract: Objectives: The aim of this study was to estimate the prevalence of impaired fasting glucose (IFG) 
among Omani adults with no family history (FH) of diabetes and to investigate the factors behind the risk of 
developing type 2 diabetes (T2D), while excluding a FH of diabetes. Methods: A total of 1,182 Omani adults, aged 
≥40 years, visited the Family Medicine & Community Health Clinic at Sultan Qaboos University Hospital, Oman, 
on days other than the Diabetes Clinic days, from July 2010 to July 2011. The subjects were interviewed and 
asked if they had T2D or a FH of T2D. Results: Only 191 (16%) reported no personal history of T2D or FH of the 
disease. Of these, anthropometric and biochemical data was complete in 159 subjects. Of these a total of 42 (26%) 
had IFG according to the American Diabetes Association criteria. Body mass index, fasting insulin, haemoglobin 
A1C and blood pressure (BP), were significantly higher among individuals with IFG (P <0.01, P <0.05, P <0.01 and 
P <0.01, respectively). In addition, fasting insulin, BP and serum lipid profile were correlated with obesity indices 
(P <0.05). Obesity indices were strongly associated with the risk of IFG among Omanis, with waist circumference 
being the strongest predictor. Conclusion: Despite claiming no FH of diabetes, a large number of Omani adults 
in this study had a high risk of developing diabetes. This is possibly due to environmental factors and endogamy. 
The high prevalence of obesity combined with genetically susceptible individuals is a warning that diabetes could 
be a future epidemic in Oman.
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لي�س  الذين  العمانيني  الأ�صخا�س  ال�صكري يف جمموعة من  اإنت�صار مرحلة ما قبل  اإىل تقديرمعدل  الدرا�صة  الهدف:  تهدف هذه  امللخ�ص: 
لديهم تاريخ عائلي للنوع الثاين من داء ال�صكري، وكذلك التحقيق يف عوامل الختطار وراء الإ�صابة بالنوع الثاين من ال�صكري مع اإ�صتبعاد 
وجود تاريخ عائلي لل�صكري. الطريقة: متت درا�صة عدد 1,182 �صخ�صًا عمانيًا، اأعمارهم 40≤ �صنة، من املراجعني لعيادة طب الأ�رشة و 
املجتمع يف م�صت�صفى جامعة ال�صلطان قابو�س،عمان،يف غري اأيام عيادة ال�صكري خلل الفرتة من يوليو 2010 اإىل يوليو 2011. متت 
مقابلة الأ�صخا�س وال�صتف�صار عن اإ�صابتهم بال�صكري اأو وجود تاريخ عائلي للنوع الثاين من مر�س ال�صكري. النتائج:  اإدعى عدد 191 
)%16( �صخ�صًا فقط اأنهم غري م�صابني مبر�س ال�صكري اأو عدم وجود تاريخ عائلي لديهم ملر�س ال�صكري. اأكمل 159 �صخ�صا فقط من هذه 
املجموعة القيا�صات اجل�صمية  والبيوكيميائية. مت ت�صنيف جمموع 42 )%26( �صخ�صا كم�صابني باعتلل ما قبل ال�صكري ح�صب معايري 
الدم  A1C، و�صغط  ال�صوم، هيموغلوبني  الإن�صولني وقت  ال�صكري. كانت قيا�صات من�صب كتلة اجل�صم، م�صتوى  الأمريكية ملر�س  مرتفعة بني الأ�صخا�س الذين هم يف مرحلة ما قبل ظهور ال�صكري. و قد لوحظ اأرتباط ن�صبة الن�صولني وقت ال�صيام، و�صغط الدم ون�صبة اجلمعية 
الدهون يف الدم مع موؤ�رشات ال�صمنة. معدلت ال�صمنة كانت مرتبطة ب�صدة بعامل الإ�صابة مبرحلة ما قبل ال�صكري عند العمانيني، مع اعتبار 
كفاف اخل�رش منبئ قوي للإ�صابة. اخلال�صة: على رغم الإدعاء من عدم وجود تاريخ تاريخ عائلي لل�صابة بال�صكري مت الإ�صتنتاج اأن 
عدد كبري من الأ�صخا�س العمانيني يف هذه الدرا�صة كان لديهم عوامل اختطار عالية للإ�صابة مبر�س ال�صكري. وهذا يعترب نتيجة لعوامل 
بيئية وزواج الأقارب. اأرتفاع معدل ال�صمنة بالإ�صرتاك مع ال�صتعداد الوراثي لل�صخ�س يعترب حتذير من اأن مر�س ال�صكري ميكن اأن يتوطن 
يف امل�صتقبل يف عمان.
مفتاح الكلمات: مرحلة ما قبل ال�صكري، مر�س ال�صكري، النوع الثاين، ال�صمنة، معدل، عمان.
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Type 2 diabetes (T2D) has a strong genetic component and its heritability has been estimated at approximately 25%.1 To 
date, more than 70 common T2D susceptibility gene 
variants and loci have been identified; however, all 
these common gene variants only explain ~10–15% 
of the heritability of T2D, suggesting that other rare 
variants have yet to be discovered.2,3
T2D is also known to cluster amongst relatives 
whose households share similar environmental, 
dietary and cultural lifestyles.4 Recent studies have 
further demonstrated the impact of obesity and 
environmental factors on the risk of developing 
T2D.5,6 The InterAct Project study showed that the 
interaction between obesity and a family history (FH) 
of diabetes increases the risk of T2D by more than 
20-fold compared with lean subjects without a FH of 
T2D.6 As body mass index (BMI) is influenced by both 
environmental and genetic factors, this interaction 
could be attributed to gene-environment and gene-
gene interactions.5
The Expert Committee on the Diagnosis and 
Classification of Diabetes Mellitus, working under the 
sponsorship of the American Diabetes Association 
(ADA), defined prediabetics in 1997 and 2003 as an 
intermediate group of individuals whose glucose 
levels are elevated above normal values but are not 
high enough to be classified as having T2D.7‒9 These 
individuals were defined as having impaired fasting 
glucose (IFG), i.e. fasting plasma glucose levels of 
5.6–6.9 mmol/L, or impaired glucose tolerance (IGT) 
with values of 7.8–11.0 mmol/L in the two-hour oral 
glucose tolerance test. The World Health Organization 
(WHO), on the other hand, defines the cut-off for 
IFG at 6.1 mmol/L rather than the 5.6 mmol/L value 
defined by the ADA.10 Therefore, the exact number of 
individuals with IFG differs according to the definition 
used.
Over a 10-year period, IFG carries a 50% risk of 
progression to T2D. In a recent study, the progession 
to T2D was reported to occur in under three years.11 
The prediabetic state is also associated with abdominal 
obesity, insulin resistance, dyslipidaemia and 
hypertension.
One in nine adults in the Middle East and North 
Africa have diabetes and more than half of them are 
unaware of their condition.12 In addition, 6.7% of 
the population in this region have IGT; this number 
is expected to double by 2030.12 Following the oil 
boom of the past four decades, major socioeconomic 
changes have taken place in Oman and other Arabian 
Gulf countries. These include rapid urbanisation and 
Westernisation, with increased levels of inactivity and 
changes in food habits. Four countries in this region 
(Kuwait, Saudi Arabia, Qatar and Bahrain) are among 
the 10 countries in the world with the highest T2D 
prevalence for adults aged 20‒79 years.12 In addition to 
the lifestyle, activity and dietary changes brought about 
by rapid economic development, these populations 
have a high genetic susceptibility due to the frequency 
of consanguineous marriages and endogamy.13,14
In Oman, according to the National Health Surveys 
of 1991 and 2000, the prevalence of diabetes mellitus 
rose from 8.3% in 1991 to 11.6% in 2000 among adults 
aged 20 years or older.15 The survey also showed that 
7.1% of men and 5.1% of women had IFG.16 Other 
studies, using the ADA criteria, have shown that 
abnormal glucose metabolism is common in Omanis, 
with 35% of adults having prediabetes.17,18 The 
Ministry of Health (MOH) in Oman has accordingly 
established a nationwide screening programme to 
detect prediabetes among those aged ≥40 years.19
This study aimed to determine the prevalence of 
IFG among a group of Omani adults claiming not to 
have a FH of diabetes. The risk factors of developing 
T2D among these Omani adults were also investigated.
Methods
This hospital-based cross-sectional study recruited 
subjects from a primary healthcare clinic, the Family 
Medicine & Community Health Clinic (FAMCO) 
at Sultan Qaboos University Hospital (SQUH) in 
Muscat, Oman. FAMCO offers a range of services, 
including: general appointments; dermatology 
consultations; walk-in appointments; Diabetes Clinic 
days; antenatal, postnatal and baby care; birth spacing 
advice; immunisations, and general counselling.
A total of 1,182 Omani adults aged ≥40 years 
visited FAMCO with general appointments on days 
other than the Diabetes Clinic days from July 2010 
to July 2011. All of the subjects were interviewed and 
asked whether they had T2D and/or a FH of T2D in 
their first-degree relatives. Pregnant women were not 
included in the study. Inclusion and exclusion criteria 
are explained in Figure 1.
Out of the 1,182 subjects, 191 (16%) reported not 
having T2D or a FH of the disease. These subjects were 
then asked to fast overnight and report the following 
morning for glucose measurements. According to their 
fasting glucose results, they were classified into three 
categories using the ADA criteria: normoglycaemic 
(<5.6 mmol/L), IFG  (5.6‒6.9 mmol/L) or diabetic 
(≥7.0 mmol/L). Participants were also classified as 
having IFG according to the 2006 WHO diagnostic 
criteria (6.1‒6.9 mmol/L). Of the 191 test subjects, 
32 were excluded either because they were found to 
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have frank diabetes (5) or because they did not report 
back for fasting glucose measurement (27). After these 
exclusions, complete data were obtained from the 
remaining 159 subjects.
Demographic (age and sex), anthropometric 
(height, weight, waist and hip circumference) and 
biochemical information was collected from all of these 
subjects. Their obesity status was also determined 
using the international classification of BMI (weight 
in Kg/height in m2).20 The subjects were classified as 
being normal if they had a BMI of 18.50‒24.99 Kg/
m2, overweight with a BMI of 25.00‒29.99 Kg/m2 and 
obese with a BMI of ≥30.00 Kg/m2. Height and weight 
were measured using standard methods with the 
subjects wearing indoor clothes without shoes.
Waist circumference (WC) was measured in cm 
at a midway level between the lower rib margin and 
iliac crest using a non-stretchable measuring tape. 
Hip circumference was measured in cm around the 
widest portion of the buttocks using a non-stretchable 
measuring tape with the tape parallel to the floor. A 
WC of ≥94 cm for males and ≥80 cm for females was 
considered to be a risk factor for insulin resistance.21
The waist-to-hip ratio (WHR) was also calculated 
for each subject. The WHR was considered a health 
risk for males according to the following ranges: low 
risk was considered for a WHR of 0.95 or below, 
moderate risk at 0.96 to 1.0 and high risk for a WHR 
of over 1.0.  Female WHR was considered a health risk 
according to the following ranges: low risk for a WHR 
of 0.80 or below, moderate risk at 0.81 to 0.85 and high 
risk for those with a WHR of over 0.85.22 
Blood pressure (BP) was also measured in mmHg 
for all of the subjects by nurses using standard 
methods. The biochemical investigations included 
measurements of fasting glucose levels, fasting 
insulin, glycated haemoglobin (HbA1C), serum 
creatinine, serum lipid profile (total cholesterol, low 
density lipoprotein [LDL] cholesterol, high density 
lipoprotein [HDL] cholesterol and triglycerides) and 
apolipoprotein B.
The Statistical Package for the Social Sciences 
(SPSS) software, Version 20.0 (IBM, Corp., Chicago, 
Illinois, USA), was used for the statistical analysis 
of the data. The anthropometric and biochemical 
parameters were tested for normal distribution 
using the one-sample Kolmogorov-Smirnov test. The 
Student’s t-test was used to test the significance of the 
difference in the mean values for the parameters with 
a normal distribution, while the Mann-Whitney U test 
was used for the variables with a skewed distribution. 
In addition, bivariate correlation and simple linear 
regression analyses were carried out to evaluate the 
influence of obesity indices (BMI, WC and WHR) on 
diabetes-related parameters.
All of the subjects were informed about the 
project and provided written consent. This study was 
approved by the Ethics & Research Committee of 
the College of Medicine & Health Sciences at Sultan 
Qaboos University, Oman.
Results
According to the ADA criteria,7 42 (26%) of the 159 
participants had IFG (males = 19, females = 23). 
However, according to the 2006 WHO diagnostic 
Figure 1: The setting, design and population of the current hospital-based cross-sectional study.
FAMCO = Family Medicine & Community Health Clinic; SQUH = Sultan Qaboos University Hospital; T2D = type 2 diabetes; FH = family 
history; WHO = World Health Organization; IFG = impaired fasting glucose; ADA = American Diabetes Association.
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criteria, only 15 (9.4 %) had IFG.
Table 1 shows the demographic, anthropometric 
and biochemical characteristics of the IFG and 
normoglycaemic groups. Age, weight, BMI, BP, 
fasting glucose, fasting insulin and HbA1C levels 
were significantly different between the IFG and 
normoglycaemic subjects. There was approximately 
a five-year age difference between the two groups 
(P <0.01). The mean BMI among IFG subjects was in 
the obese range, while the mean for normoglycaemics 
was in the overweight range (P <0.01). The prevalence 
of overweight and obese subjects among the IFG 
and normoglycaemic subjects were 88% and 74%, 
respectively.
With regards to WC, 37% and 91% of IFG males 
and females, respectively, had an elevated WC, while 
41% and 88% of normoglycaemic males and females, 
respectively, had an elevated WC.20 In addition, the 
mean value of the participants’ WHRs indicated 
moderate risk among males with IFG (0.96 ± 0.05 cm) 
but low risk among normoglycaemic males (0.95 ± 
0.04 cm). However, it indicated high risk in both IFG 
(0.94 ± 0.1 cm) and normoglycaemic (0.92 ± 0.1 cm) 
females.
There was no significant difference in the serum 
lipids concentrations among IFG and normoglycaemic 
subjects. However, total cholesterol and LDL 
cholesterol mean values were borderline high, while 
HDL cholesterol was moderately low among both 
groups [Table 1].
Tables 2 and 3 show the results of the Pearson 
correlation and simple linear regression analyses, 
respectively. Increased fasting insulin, systolic 
and diastolic BP and serum lipids were found to 
correlate significantly with an increase in obesity 
indices. Approximately 48% (r2 = 0.48) and 33% 
(r2 = 0.33) of the variance of the fasting insulin and 
11% (r2 = 0.11) and 4% (r2 = 0.04) of the variance of 
the diastolic BP among IFG and normoglycaemic 
subjects, respectively, could be accounted for by an 
increase in WC. In addition, 15% (r2 = 0.15) and 8% 
(r2 = 0.08) of the variance of the systolic BP among 
IFG and normoglycaemic subjects, respectively, 
could be accounted for by an increase in WHR. 
For the lipids profile, approximately 18% (r2 = 0.18) 
of the variance of the total cholesterol and 14% 
(r2= 0.14) of the variance of the triglycerides among 
IFG subjects could be accounted for by an increase in 
WHR. Both the Pearson correlation and simple linear 
regression analyses revealed that the increase in WC 
had a stronger influence on the parameters related to 
diabetes than the increase in BMI.
Discussion
This study was conducted on a random hospital cohort 
of 159 Omani adults who reported no personal or FH 
of T2D and who were not excluded due to incomplete 
data or other exclusion criteria. Using the ADA 
criteria, 26% of those who were unaware of a personal 
or FH of diabetes had IFG. However, using the WHO 
criteria, IFG was found in 9.4%. This is considered a 
high percentage among this unique sample of subjects 
Table 1: Demographic, anthropometric and biochemical 
characteristics of the impaired fasting glucose and 
normoglycaemic groups of Omani participants with no 
family history of type 2 diabetes (N = 159)







Mean ± SD Mean ± SD
Age in years (range) 52 ± 10 46 (35‒79)* <0.01
Weight in Kg 77 ± 15 72 ± 13 <0.05
Height in cm 156 ± 11 157 ± 8 0.478
BMI in Kg/m2 32 ± 8 29 ± 5 <0.01
WC in cm 96 ± 11 92 ± 14 0.099
Hip circumference 
in cm (range)
99 ± 9 97 
(76‒191)*
0.223
WHR 0.97 ± 0.1 0.94 ± 0.1 0.076
Systolic BP in mmHg 138 ± 20 127 ± 20 <0.01
Diastolic BP in 
mmHg
81 ± 10 77 ± 9 <0.01




4.9 ± 0.4 <0.001
Fasting insulin in 
mIU/L
9.9 ± 5.4 7.4 ± 3.9 <0.05
HbA1C in % 5.9 ± 0.5 5.7 ± 0.4 <0.01
Serum creatinine in 
μmol/L
69 ± 20 63 ± 16 0.071
Total cholesterol in 
mmol/L
5.5 ± 1.0 5.4 ± 0.9 0.575
LDL cholesterol in 
mmol/L
3.5 ± 1.1 3.5 ± 0.9 0.803
HDL cholesterol in 
mmol/L
1.2 ± 0.3 1.3 ± 0.3 0.339
Triglycerides in 
mmol/L (range)





1.0 ± 0.2 1.0 ± 0.3 0.621
IFG = impaired fasting glucose; SD = standard deviation; BMI = body 
mass index; WC = waist circumference; WHR = wasit-to-hip ratio; BP 
= blood pressure; HbA1C = glycated haemoglobin; LDL = low-density 
lipoprotein; HDL = high-density lipoprotein.
*The median (range of minimum–maximum) is displayed if the 
variable does not follow a normal distribution pattern.
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with no FH of diabetes. The risk factors for diabetes, 
such as age and BMI, were found to be significantly 
higher among subjects with IFG compared to the 
normoglycaemic group. Furthermore, diabetes-
associated conditions, such as an increase in fasting 
insulin, HbA1C and BP, were significantly higher among 
subjects with IFG compared to normoglycaemics. 
Obesity indices had some influence on the measured 
parameters among both IFG and normoglycaemic 
subjects. An increase in obesity indices seems to 
correlate with an increase in fasting insulin, BP and 
serum lipids.
The findings of this study are in agreement with 
previous Omani studies, where the isolated IFG 
prevalence among Omani adults was reported at 30% 
using the ADA criteria.18 However, it was reported at 
6.1% (in subjects ≥20 years) and 8.3% (in subjects ≥30 
years) using the WHO criteria.15,23 The Oman World 
Health Survey (OWHS), also using the WHO criteria, 
estimated the prevalence of prediabetes among Omani 
adults at 4.4% in those aged ≥18 years, 8.4% in those 
aged 45‒54 years and 11.2% in those aged 55‒64 
years.22
Using the WHO criteria, IFG among Emiratis 
(8.8%) was very similar to the Omani figures.25 However, 
using the ADA criteria, it was reported at 1.3% among 
Qataris and 3.1% among Saudis.26,27 These values are 
considered low in comparison with the prevalence of 
diabetes among their populations. Furthermore, using 
the ADA criteria, IFG was found to be 13.8% among 
Kuwaitis.28 In Spain, IFG was reported at 2.8% and 
3.4% (using the WHO criteria), while in the USA it was 
reported at 26% (using the ADA criteria).29‒31
Table 2: Pearson correlation (r) of measured biochemical paramenters with body mass index, waist circumference 
and waist-to-hip ratio among the impaired fasting glucose and normoglycaemic groups of Omani patients (N = 159)
Biochemical parameters Pearson correlation (r)
BMI WC WHR
IFG NGG IFG NGG IFG NGG
Fasting insulin in mIU/L 0.223 0.501** 0.691** 0.576** 0.440** 0.227*
Systolic BP in mmHg 0.113 0.193* 0.189 0.249** 0.387* 0.282**
Diastolic BP in mmHg 0.177 0.143 0.331* 0.210* 0.195 0.288**
Total cholesterol in mmol/L 0.048 0.104 0.254 0.188* 0.421** 0.118
HDL cholesterol in mmol/L 0.251 -0.119 0.008 -0.227* -0.161 -0.186
Triglyceride in mmol/L 0.054 0.133 0.228 0.187 0.370* 0.235*
Apolipoprotein B in g/L -0.132 0.127 0.070 0.277** 0.242 0.299**
BMI = body mass index; WC = waist circumference; WHR = waist-to-hip ratio; IFG = impaired fasting glucose group; NGG = normoglycaemic 
group; BP = blood pressure; HDL = high-density lipoprotein.
*Significant at the P <0.05 level (two-tailed); **Significant at the P <0.01 level (two-tailed).
Table 3: Regression coefficient (B) of measured biochemical parameters with body mass index, waist circumference 
and waist-to-hip ratio among the impaired fasting glucose and normoglycaemic groups of Omani patients (N = 159)
Biochemical parameters Regression coefficient
BMI WC WHR
IFG NGG IFG NGG IFG NGG
Fasting insulin in mIU/L 0.137 0.373** 0.316** 0.216** 29** 10.2*
Systolic BP in mmHg 0.274 0.753* 0.333 0.496** 97* 71**
Diastolic BP in mmHg 0.218 0.247 0.296* 0.182* 24.8 31.8**
Total cholesterol in mmol/L 0.006 0.018 0.021 0.012* 5.0** 1.3
HDL cholesterol in mmol/L 0.008 -0.007 0.0 -0.005* -0.540 -0.698
Triglyceride in mmol/L 0.006 0.019 0.017 0.010 3.9* 2.1*
Apolipoprotein B in g/L -0.005 0.006 0.001 0.005** 0.662 0.861**
BMI = body mass index; WC = waist circumference; WHR = waist-to-hip ratio; IFG = impaired fasting glucose group; NGG = normoglycaemic 
group; BP = blood pressure; HDL = high-density lipoprotein.
*Significant at the P <0.05 level (two-tailed); **Significant at the P <0.01 level (two-tailed).
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In Omani subjects, 88% of the IFG subjects 
were either overweight or obese compared to 74% 
of the normoglycaemic group. A recent study found 
that 51% of Omani adults and 75% of isolated IFG 
individuals were either overweight or obese.18 Among 
the Qatari population, 86% of diabetics and 75% of 
normoglycaemics were overweight or obese.26 These 
findings are similar to the figures found in the subjects 
of the current study. Family and twin studies have 
shown that BMI and abdominal obesity, measured by 
WC or WHR, is 40–60% heritable.32,33
In this study, it was found that an increase in 
WC had a stronger influence on diabetes-associated 
conditions than an increase in BMI. Approximately 
48% and 33% of the variance of the fasting insulin 
among IFG and normoglycaemic subjects, 
respectively, could be accounted for by an increase 
in WC. These results are similar to an earlier study, 
which found that all three indices of obesity were 
strongly and independently associated with the risk 
of T2D among Omanis, with WC being the strongest 
predictor.34 In this study, Omani females were found to 
have a higher prevalence of elevated WC than Omani 
males. Furthermore, females with IFG were found 
to have a higher prevalence of elevated WC than 
normoglycaemic females. The mean value of WHR 
indicated a moderate risk among males with IFG, but 
a low risk among normoglycaemic males. However, it 
indicated high risk in both IFG and normoglycaemic 
females. In a previous study, the prevalence of elevated 
WC among Omanis was found to be 23% and 65% 
among males and females, respectively.35
In a complex disease like diabetes, with a multitude 
of potential interacting genes and environmental 
factors, and with no control for socioeconomic status 
or endogamy, the outcome of the current study is not 
surprising.14 This study found a high prevalence of 
IFG in an Omani cohort of subjects with no FH of 
diabetes; therefore, the high prevalence is believed 
to be due primarily to changes in diet and lifestyle. 
However, it may not be possible to claim this as 
the precise cause, since Oman has an endogamous 
society where approximately half of all marriages are 
consanguineous.36 Therefore, the Omani subjects 
in this study may still have had diabetic ancestors of 
whom they were unaware.14,37,38 Also, obesity, which 
is a major predisposing factor for diabetes, has both 
genetic and environmental elements.
The main limitation of this study was the small 
sample size. However, this study aimed to separate the 
influence of genetics from the environmental factors 
of developing T2D among the Omani population. 
Previous studies among the Omani population 
concentrated on finding the prevalence of IFG among 
the whole population. This study discovered that 
obesity among the Omani population has a strong 
effect on developing T2D, even without the presence 
of a FH of diabetes.
The difficulty in recruiting Omani adults with 
no FH of diabetes was the main reason for the small 
sample of subjects in this study as almost everybody 
has a relative with diabetes mellitus.
Conclusion
In this study, 26% of the Omani population sample 
reported no FH of diabetes, but had IFG. Obesity 
indices are strongly associated with the risk of IFG and 
T2D among Omanis, with WC being the strongest 
predictor. The high prevalence of central obesity 
among this Omani population acting on genetically 
susceptible individuals warns of a future diabetes 
epidemic in Oman. Health education programmes 
could make a substantial difference in promoting 
lifestyle modifications, which are important tools to 
prevent diabetes and its complications.
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